MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2003-01-27
Last Posted Date
2013-07-25
Lead Sponsor
Yale University
Target Recruit Count
10
Registration Number
NCT00003111
Locations
🇺🇸

Yale Comprehensive Cancer Center, New Haven, Connecticut, United States

Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder

Phase 1
Completed
Conditions
Premenstrual Syndrome
Interventions
Other: Treatment as usual (TAU)
First Posted Date
2002-11-13
Last Posted Date
2016-01-12
Lead Sponsor
Yale University
Target Recruit Count
66
Registration Number
NCT00048854
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations

Not Applicable
Completed
Conditions
Schizophrenia
Hallucinations
First Posted Date
2002-07-26
Last Posted Date
2013-08-06
Lead Sponsor
Yale University
Target Recruit Count
50
Registration Number
NCT00042159
Locations
🇺🇸

Yale-New Haven Psychiatric Hospital, New Haven, Connecticut, United States

Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial

Phase 3
Completed
Conditions
Intraventricular Hemorrhage (IVH)
Bleeding in the Brain
Prematurity
Very Low Birth Weight Infants
Interventions
Drug: placebo
First Posted Date
2002-04-15
Last Posted Date
2013-03-28
Lead Sponsor
Yale University
Target Recruit Count
630
Registration Number
NCT00033917
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

🇺🇸

Maine Medical Center, Portland, Maine, United States

🇺🇸

Brown University School of Medicine, Providence, Rhode Island, United States

Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

Phase 3
Completed
Conditions
Substance-Related Disorders
First Posted Date
2002-04-08
Last Posted Date
2017-01-12
Lead Sponsor
Yale University
Target Recruit Count
561
Registration Number
NCT00032981
Locations
🇺🇸

Tarzana Treatment Center, Tarzana, California, United States

🇺🇸

CT Renaissance, Inc., Norwalk, Connecticut, United States

🇺🇸

Haight Ashbury Free Clinics, San Francisco, California, United States

and more 3 locations

Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1

Phase 3
Completed
Conditions
Substance-Related Disorders
First Posted Date
2002-04-08
Last Posted Date
2017-01-12
Lead Sponsor
Yale University
Target Recruit Count
422
Registration Number
NCT00032994
Locations
🇺🇸

Willamette Family Treatment Services, Eugene, Oregon, United States

🇺🇸

Lower Eastside Service Center (LESC), New York, New York, United States

🇺🇸

Chesterfield County CSB- Substance Abuse Services, Chesterfield, Virginia, United States

and more 2 locations

Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1

Phase 2
Completed
Conditions
Heroin Dependence
Substance Abuse, Intravenous
Opioid-Related Disorders
Interventions
First Posted Date
2001-08-31
Last Posted Date
2020-06-29
Lead Sponsor
Yale University
Registration Number
NCT00023283
Locations
🇺🇸

APT Residential Services Division, New Haven, Connecticut, United States

Isocyanate Antigens and T Cells That Cause Asthma

Completed
Conditions
Asthma
Lung Diseases
First Posted Date
2000-05-26
Last Posted Date
2014-03-14
Lead Sponsor
Yale University
Registration Number
NCT00005549

Repetitive Transcranial Magnetic Stimulation for "Voices"

Phase 2
Completed
Conditions
Schizophrenia
Interventions
Device: repetitive transcranial magnetic stimulation (rTMS)
Device: sham stimulation
First Posted Date
2000-03-13
Last Posted Date
2013-08-07
Lead Sponsor
Yale University
Target Recruit Count
50
Registration Number
NCT00004980
Locations
🇺🇸

Yale University School of Medicine, New Haven, Connecticut, United States

Acamprosate Treatment: Mechanisms of Action

Phase 2
Completed
Conditions
Alcoholism
First Posted Date
2000-02-04
Last Posted Date
2015-07-02
Lead Sponsor
Yale University
Target Recruit Count
120
Registration Number
NCT00004552
Locations
🇺🇸

Substance Abuse Treatment Unit, University of Connecticut, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath